2178 31 12158 5 63308 document 12158 2178_UserGuide.html text/html 464ffd08c99ee955353aa938fcf7880c11b5660d77f7f1209bb49e4301810d6a SHA256 11565 2022-01-12 16:07:02 https://datacompass.lshtm.ac.uk/id/eprint/2178/1/2178_UserGuide.html 2178 1 4 text/html Text en public cc_by

2178_UserGuide.html

documentation indefinite User guide for data extraction sheet 12159 5 63310 document 12159 DataExtractionSheet-Proportion_of_RVF_symptoms_Codebook.html text/html 4313c05e867b29085e1f45ed18ddc842538a57f5be15dd0742f5d74ddb85ba08 SHA256 30099 2022-01-12 16:07:30 https://datacompass.lshtm.ac.uk/id/eprint/2178/2/DataExtractionSheet-Proportion_of_RVF_symptoms_Codebook.html 2178 2 3 text/html Text en public cc_by

DataExtractionSheet-Proportion_of_RVF_symptoms_Codebook.html

documentation indefinite Codebook for Data Extraction Sheet - Proportion of RVF symptoms 12160 4 63312 document 12160 DataExtractionSheet-Proportion_of_RVF_symptoms.xlsx application/vnd.openxmlformats-officedocument.spreadsheetml.sheet 9b45088b9867d200b74b15b61e6f20834b53ecfbf21dd8ff34bdc4ca8b6f4ee8 SHA256 59707 2022-01-12 16:09:08 https://datacompass.lshtm.ac.uk/id/eprint/2178/3/DataExtractionSheet-Proportion_of_RVF_symptoms.xlsx 2178 3 2 application/vnd.openxmlformats-officedocument.spreadsheetml.sheet Dataset en public cc_by

DataExtractionSheet-Proportion_of_RVF_symptoms.xlsx

data indefinite Data extraction sheet - Proportion of symptoms 12161 3 63314 document 12161 DataExtractionSheet-Symptoms_clinical_syndromes.xlsx application/vnd.openxmlformats-officedocument.spreadsheetml.sheet 02ecc99318b076b3c23c5296f22c596d87f0bdfe3da0468e58b85880e6a2f707 SHA256 35651 2022-01-12 16:09:17 https://datacompass.lshtm.ac.uk/id/eprint/2178/4/DataExtractionSheet-Symptoms_clinical_syndromes.xlsx 2178 4 1 application/vnd.openxmlformats-officedocument.spreadsheetml.sheet Dataset en public cc_by

DataExtractionSheet-Symptoms_clinical_syndromes.xlsx

data indefinite File contains a description of the clinical presentation (Signs or Symptom) and Laboratory (Blood and CSF) parameters 17063 1 95389 document 17063 indexcodes.txt text/x-c b9613a09d618770aff6e8e9b1639b4d3bd2ae5e3218463197076565c94c4d86f SHA256 3976 2025-02-07 10:19:55 https://datacompass.lshtm.ac.uk/id/eprint/2178/5/indexcodes.txt 2178 5 5 text/x-c en public

indexcodes.txt

http://eprints.org/relation/isVersionOf https://datacompass.lshtm.ac.uk/id/document/12158 http://eprints.org/relation/isVolatileVersionOf https://datacompass.lshtm.ac.uk/id/document/12158 http://eprints.org/relation/isIndexCodesVersionOf https://datacompass.lshtm.ac.uk/id/document/12158 indefinite Generate index codes conversion from Text to indexcodes 17064 1 95390 document 17064 indexcodes.txt text/plain 0723855d5f4faf739943903e46be3ed5d1bc9d6f43b8d2f40e0ee7531e8f8194 SHA256 6978 2025-02-07 10:19:55 https://datacompass.lshtm.ac.uk/id/eprint/2178/6/indexcodes.txt 2178 6 6 text/plain en public

indexcodes.txt

http://eprints.org/relation/isVersionOf https://datacompass.lshtm.ac.uk/id/document/12159 http://eprints.org/relation/isVolatileVersionOf https://datacompass.lshtm.ac.uk/id/document/12159 http://eprints.org/relation/isIndexCodesVersionOf https://datacompass.lshtm.ac.uk/id/document/12159 indefinite Generate index codes conversion from Text to indexcodes archive 3 disk0/00/00/21/78 2021-06-01 10:10:22 2025-10-31 14:20:41 2021-06-01 10:10:22 data_collection show Anywaine Zacchaeus 0000-0001-5771-5515 TRUE 633b9c96d229d25e475b3ef8d4841272 Lule Swaib Abubaker FALSE Hansen Christian 0000-0002-5949-0097 TRUE ca34894f5aa48c59500147b61f633885 Warimwe George FALSE Elliott Alison 0000-0003-2818-9549 TRUE d9d54503b6d617709b2d9f1aaf480651 Researcher Kakande Ayoub TRUE 8bf8767af4fafc53c9f9d69fd71442f8 London School of Hygiene & Tropical Medicine, London, United Kingdom MRC/UVRI and LSHTM Uganda Research Unit ITCR MRCUVRI Rift Valley fever RVF Clinical manifestations Syndromes Data extraction in this study was aimed at achieving three main purposes: (1) obtain data that describe the characteristics of the included studies, (2) obtain data for assessing the quality of included studies, and (3) obtain data for synthesizing the frequency and duration of clinical manifestations and duration of illness since onset to diagnosis. Information was abstracted on the characteristics of eligible studies including first author’s surname, year of publication, type of article (abstract or full text), list of countries where the study was conducted, information on the study design (cohort, cross sectional/outbreak investigation, intervention studies, case series, reviews); demographics (number of participants that were enrolled, age, sex and nationality); laboratory tests used to confirm diagnosis of RVF (enzyme linked immunosorbent assay or ELISA (IgM & IgG), real-time polymerase chain reaction (rtPCR) or quantitative polymerase chain reaction (qPCR), plaque reduction neutralisation test (PRNT) and focus reduction neutralisation test (FRNT) or other serological and viral antigen tests etc). Data on the number or proportion that had co-infections and type of co-infection such as hepatitis B, malaria, schistosomiasis etcetera were also captured. Rift Valley fever presents among humans in form of clinical syndromes including the general febrile syndrome, hepatic or abdominal syndrome, encephalitis syndrome, visual syndrome and haemorrhagic syndrome. Data was collected on several RVF clinical manifestations in humans for which proportion or description of symptoms was recorded. Data was also extracted on the frequency and levels of each laboratory parameter reported. 2021-05-17 completed London School of Hygiene & Tropical Medicine 10.17037/DATA.00002178 Dataset Study consortium Aggregation KH QB-Clinical Q-QU public London, United Kingdom Biotechnology and Biological Sciences Research Council Medical Research Council European Commission Oak Foundation Fellowship Wellcome Trust Department for International Development, UK Government Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Dataset Quantitative Electronic bibliographic databases including Medline/PubMed, Embase, Global Health and Web of Science were searched to identify relevant studies. Two people independently reviewed the abstracts of relevant papers to determine study eligibility and selected the articles for full text review and data extraction. All records from the search and selection process were captured directly into a systematic review flow schema. Data from eligible studies was extracted into two excel sheets. The two reviewers that assessed eligibility were the same persons that extracted the records from the papers. Discrepant entries between the two reviewers were resolved through discussions which were held face to face, by telephone, skype or email and the final agreed records were summarised on the excel sheets. Where two or more manuscripts report data from the same study, these were considered as one study and data was extracted on clinical manifestations that do not duplicate. The number of articles obtained through searching, number selected and number from which data was extracted was recorded and presented in a flow diagram. The studies from which data was extracted were identified by the first author’s surname. Data from the excel sheets was imported into stata analysis software. Where two or more studies were available for a particular clinical manifestation, pooled proportions of patients were presented with the parameter and their 95% confidence intervals estimated using random effects models. Sensitivity analysis was done to check the effect of study quality and study design on the pooled proportion. Forest plots were drawn where two or more studies reported a particular clinical manifestation and these were summarised by patient source. 16/107/02 en 2019-10-13 2020-06-30 https://researchonline.lshtm.ac.uk/id/eprint/4665473 Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Biotechnology and Biological Sciences Research Council 16/107/02 http://dx.doi.org/10.13039/501100000268 Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Medical Research Council 16/107/02 http://dx.doi.org/10.13039/501100000265 Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans European Commission http://dx.doi.org/10.13039/501100000780 Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Oak Foundation Fellowship Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Wellcome Trust 203077_Z_16_Z http://dx.doi.org/10.13039/100010269 Systematic review study protocol investigating the clinical manifestations and long-term complications of Rift Valley fever in humans Department for International Development, UK Government http://dx.doi.org/10.13039/501100002992 2021-05-17